181 related articles for article (PubMed ID: 34567065)
1. Expression Profiles of Circulating microRNAs in South African Type 2 Diabetic Individuals on Treatment.
Weale CJ; Matshazi DM; Davids SFG; Raghubeer S; Erasmus RT; Kengne AP; Davison GM; Matsha TE
Front Genet; 2021; 12():702410. PubMed ID: 34567065
[No Abstract] [Full Text] [Related]
2. Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus.
Weale CJ; Matshazi DM; Davids SFG; Raghubeer S; Erasmus RT; Kengne AP; Davison GM; Matsha TE
Diabetes Metab Syndr Obes; 2020; 13():5037-5047. PubMed ID: 33376373
[TBL] [Abstract][Full Text] [Related]
3. Expression of whole blood miR-126-3p, -30a-5p, -1299, -182-5p and -30e-3p in chronic kidney disease in a South African community-based sample.
Motshwari DD; George C; Matshazi DM; Weale CJ; Davids SFG; Zemlin AE; Erasmus RT; Kengne AP; Matsha TE
Sci Rep; 2022 Mar; 12(1):4107. PubMed ID: 35260775
[TBL] [Abstract][Full Text] [Related]
4. Identifying Key MicroRNAs Targeted by Narenmandula in a Rodent Nephropathy Model.
Wang X; Chang C; Jin W; Arun A; Sudunabuqi S; Aodaofu A; Liu X; Wu F; Chen H
Evid Based Complement Alternat Med; 2020; 2020():9196379. PubMed ID: 33299464
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs-1299, -126-3p and -30e-3p as Potential Diagnostic Biomarkers for Prediabetes.
Weale CJ; Matshazi DM; Davids SFG; Raghubeer S; Erasmus RT; Kengne AP; Davison GM; Matsha TE
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34073154
[TBL] [Abstract][Full Text] [Related]
6. Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.
Purvis N; Kumari S; Chandrasekera D; Bellae Papannarao J; Gandhi S; van Hout I; Coffey S; Bunton R; Sugunesegran R; Parry D; Davis P; Williams MJA; Bahn A; Katare R
Diabetologia; 2021 Jun; 64(6):1422-1435. PubMed ID: 33655378
[TBL] [Abstract][Full Text] [Related]
7. Circulating Levels of MicroRNAs Associated With Hypertension: A Cross-Sectional Study in Male and Female South African Participants.
Matshazi DM; Weale CJ; Erasmus RT; Kengne AP; Davids SFG; Raghubeer S; Davison GM; Matsha TE
Front Genet; 2021; 12():710438. PubMed ID: 34594360
[TBL] [Abstract][Full Text] [Related]
8. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
9. Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people.
Morrison KR; Solly EL; Shemesh T; Psaltis PJ; Nicholls SJ; Brown A; Bursill CA; Tan JTM
Diabetologia; 2021 Jun; 64(6):1402-1411. PubMed ID: 33651121
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profile in retina and choroid in oxygen-induced retinopathy model.
Desjarlais M; Rivera JC; Lahaie I; Cagnone G; Wirt M; Omri S; Chemtob S
PLoS One; 2019; 14(6):e0218282. PubMed ID: 31188886
[TBL] [Abstract][Full Text] [Related]
11. MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications.
Olivieri F; Spazzafumo L; Bonafè M; Recchioni R; Prattichizzo F; Marcheselli F; Micolucci L; Mensà E; Giuliani A; Santini G; Gobbi M; Lazzarini R; Boemi M; Testa R; Antonicelli R; Procopio AD; Bonfigli AR
Oncotarget; 2015 Nov; 6(34):35372-82. PubMed ID: 26498351
[TBL] [Abstract][Full Text] [Related]
12. Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes.
Wander PL; Boyko EJ; Hevner K; Parikh VJ; Tadesse MG; Sorensen TK; Williams MA; Enquobahrie DA
Diabetes Res Clin Pract; 2017 Oct; 132():1-9. PubMed ID: 28783527
[TBL] [Abstract][Full Text] [Related]
13. Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
Scherbak NN; Kruse R; Nyström T; Jendle J
Diabetes Metab J; 2023 Sep; 47(5):668-681. PubMed ID: 37349083
[TBL] [Abstract][Full Text] [Related]
14. Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression.
Esteves JV; Yonamine CY; Pinto-Junior DC; Gerlinger-Romero F; Enguita FJ; Machado UF
Front Endocrinol (Lausanne); 2018; 9():536. PubMed ID: 30258406
[TBL] [Abstract][Full Text] [Related]
15. Circulating miRNAs in Type 2 Diabetic Patients with and without Albuminuria in Malaysia.
Zahari Sham SY; Ng CT; Azwar S; Yip WK; Abdullah M; Thevandran K; Osman M; Seow HF
Kidney Blood Press Res; 2022; 47(2):81-93. PubMed ID: 35158353
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis.
Assmann TS; Recamonde-Mendoza M; De Souza BM; Crispim D
Endocr Connect; 2017 Nov; 6(8):773-790. PubMed ID: 28986402
[TBL] [Abstract][Full Text] [Related]
17. [Inheritable changes in miRNAs expression in HeLa cells after X-ray and mitomycin C treatment].
Tarasov VA; Matishov DG; Shin EF; Boĭko NV; Timoshkina NN; Makhotkin MA; Lomonosov AM; Kirpiĭ AA
Genetika; 2014 Aug; 50(8):909-17. PubMed ID: 25731020
[TBL] [Abstract][Full Text] [Related]
18. Combined detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for screening of early heart failure diseases.
Ding H; Wang Y; Hu L; Xue S; Wang Y; Zhang L; Zhang Y; Qi H; Yu H; Aung LHH; An Y; Li P
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32124924
[TBL] [Abstract][Full Text] [Related]
19. Altered Plasma MicroRNA Expression in Patients with Mitral Chordae Tendineae Rupture.
Bulent Vatan M; Kalaycı Yigin A; Akdemir R; Tarik Agac M; Akif Cakar M; Aksoy M; Tatli E; Kilic H; Gunduz H; Guzel D; Karacan K
J Heart Valve Dis; 2016 Sep; 25(5):580-588. PubMed ID: 28238240
[TBL] [Abstract][Full Text] [Related]
20. miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy.
Akpınar K; Aslan D; Fenkçi SM; Caner V
Diagnosis (Berl); 2022 Nov; 9(4):499-507. PubMed ID: 35976169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]